|
N-[5-(1-benzyl-1H-1,2,3-triazol-4-yl)-1H-indazol-3-yl]-N2,N2-dimethylglycinamide |
|
CHEBI:143112 |
|
N-[5-(1-benzyl-1H-1,2,3-triazol-4-yl)-1H-indazol-3-yl]-N(2),N(2)-dimethylglycinamide |
|
A member of the class of indazoles that is 1H-indazole which is substituted by a (N,N-dimethylglycyl)nitrilo group and a 1-benzyl-1H-1,2,3-triazol-4-yl group at positions 3 and 5, respectively. It is a GSK-3β, CDK1, CDK2, CSNK1G2 and CLK4 kinase inhibitor. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
Tim Willson
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C20H21N7O/c1-26(2)13-19(28)21-20-16-10-15(8-9-17(16)22-24-20)18-12-27(25-23-18)11-14-6-4-3-5-7-14/h3-10,12H,11,13H2,1-2H3,(H2,21,22,24,28) |
FLHJZUQGFPJXRD-UHFFFAOYSA-N |
O=C(CN(C)C)NC1=NNC2=CC=C(C3=CN(CC4=CC=CC=C4)N=N3)C=C21 |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of non-specific serine/threonine protein kinase (EC 2.7.11.1), a kinase enzyme involved in phosphorylation of hydroxy group of serine or threonine.
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of cyclin-dependent kinase (EC 2.7.11.22).
EC 2.7.11.26 (tau-protein kinase) inhibitor
An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of tau-protein kinase inhibitor (EC 2.7.11.26).
|
|
View more via ChEBI Ontology
Outgoing
|
N-[5-(1-benzyl-1H-1,2,3-triazol-4-yl)-1H-indazol-3-yl]-N2,N2-dimethylglycinamide
(CHEBI:143112)
has role
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
(CHEBI:50925)
N-[5-(1-benzyl-1H-1,2,3-triazol-4-yl)-1H-indazol-3-yl]-N2,N2-dimethylglycinamide
(CHEBI:143112)
has role
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
(CHEBI:82665)
N-[5-(1-benzyl-1H-1,2,3-triazol-4-yl)-1H-indazol-3-yl]-N2,N2-dimethylglycinamide
(CHEBI:143112)
has role
EC 2.7.11.26 (tau-protein kinase) inhibitor
(CHEBI:91092)
N-[5-(1-benzyl-1H-1,2,3-triazol-4-yl)-1H-indazol-3-yl]-N2,N2-dimethylglycinamide
(CHEBI:143112)
is a
benzenes
(CHEBI:22712)
N-[5-(1-benzyl-1H-1,2,3-triazol-4-yl)-1H-indazol-3-yl]-N2,N2-dimethylglycinamide
(CHEBI:143112)
is a
indazoles
(CHEBI:38769)
N-[5-(1-benzyl-1H-1,2,3-triazol-4-yl)-1H-indazol-3-yl]-N2,N2-dimethylglycinamide
(CHEBI:143112)
is a
secondary carboxamide
(CHEBI:140325)
N-[5-(1-benzyl-1H-1,2,3-triazol-4-yl)-1H-indazol-3-yl]-N2,N2-dimethylglycinamide
(CHEBI:143112)
is a
tertiary amino compound
(CHEBI:50996)
N-[5-(1-benzyl-1H-1,2,3-triazol-4-yl)-1H-indazol-3-yl]-N2,N2-dimethylglycinamide
(CHEBI:143112)
is a
triazoles
(CHEBI:35727)
|
|
N-[5-(1-benzyl-1H-1,2,3-triazol-4-yl)-1H-indazol-3-yl]-N2,N2-dimethylglycinamide
|
AKI00000062a
|
ChEBI
|
N-[5-(1-benzyltriazol-4-yl)-1H-indazol-3-yl]-2-(dimethylamino)acetamide
|
ChEBI
|
|